SFRP2 is a secreted factor reported to antagonize WNT signaling by sequestering of WNT ligands and has been connected with increased tumor growth, metastasis and therapy resistance [38], but has also been described as a tumor suppressor [24]. The gene discussed is SFRP2; the disease is neoplasm.